Potential Lyme disease vaccine: Major test begins

Researchers are seeking thousands of volunteers to test the first potential vaccine against Lyme disease in 20 years. The shot developed by Pfizer and French biotech Valneva aims to block Lyme spread while a tick is biting.

Lyme disease vaccine trial

Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years. Lyme is a growing threat, with cases steadily rising and warming weather helping ticks expand their habitat. While a vaccine for dogs has long been available, the only human Lyme vaccine was pulled off the U.S. market in 2002, leaving people to rely on bug spray and tick checks. (By The Associated Press)

Two 'scary' diseases found in NY ticks

While Lyme disease is one of the more commonly known diseases transmitted by ticks, two others getting more attention are babesiosis, caused by a parasite, and anaplasmosis, a bacterial disease.

Lyme disease conference draws many experts

Lyme disease researchers, clinicians, patients, and advocates have gathered at a conference to discuss their single goal: curtailing and ultimately curing Lyme.

Lyme disease conference

Lyme disease researchers, clinicians, patients, and advocates have gathered at a conference to discuss their single goal: curtailing and ultimately curing Lyme. Mount Sinai researcher Savi Glowe was tasked with getting these brilliant minds in one room for the Lyme Mind Conference. This is the third year but the first to allow the public to interact directly with Lyme physicians and researchers.